BMJ · 2026-07-08
Advances in systemic therapies for advanced prostate cancer
Phrase rank #1 · DOI 10.1136/bmj-2025-085211
Conditions & diseases
prostate cancer
Observed in 92 articles across 18 journals.
Latest share0.13%
Change vs baseline-0.19 pp
Months observed13
Latest monthJul 2026
Portfolio article share
Attention over this snapshot
13 monthly points
Journal breadth
Where it appears
- Journal for ImmunoTherapy of Cancer32
- BMJ17
- BMJ Open13
- European Journal of Hospital Pharmacy5
- Journal of Clinical Pathology4
- BMJ Evidence-Based Medicine3
- Occupational and Environmental Medicine3
- BMJ Case Reports2
- BMJ Open Quality2
- BMJ Supportive & Palliative Care2
- Journal of Medical Genetics2
- BMJ Connections Oncology1
Co-occurrence
Explore nearby topics
Inspect the source signal
Article evidence
30 high-ranking examples
BMJ · 2026-06-11
Why not screening for prostate cancer is justified
Phrase rank #1 · DOI 10.1136/bmj-2026-894967
BMJ Open · 2026-05-28
Cohort profile: BioCaPPE (Biomarkers of Prostate Cancer/Prevention and Environment) – a Canadian multicentre prospective study of lifestyle and candidate biomarkers in relation to prostate cancer risk
Phrase rank #1 · DOI 10.1136/bmjopen-2025-111118
Journal for ImmunoTherapy of Cancer · 2026-05-08
LGALS9 blockade augments vaccine-induced immune responses against prostate cancer
Phrase rank #1 · DOI 10.1136/jitc-2025-014141
Journal for ImmunoTherapy of Cancer · 2026-05-04
Phase II trial of combination radiation, hormone, and immunotherapy in grade group 5 prostate cancer
Phrase rank #1 · DOI 10.1136/jitc-2025-013906
European Journal of Hospital Pharmacy · 2026-03-18
4CPS-245 Real-world incidence and management of hypothyroidism secondary to apalutamide in patients with prostate cancer
Phrase rank #1 · DOI 10.1136/ejhpharm-2026-eahp.344
European Journal of Hospital Pharmacy · 2026-03-18
4CPS-003 Beyond choline: the role of piflufolastat in guiding treatment for recurrent prostate cancer
Phrase rank #1 · DOI 10.1136/ejhpharm-2026-eahp.108
BMJ · 2026-02-10
Ethnic inequality in prostate cancer: no current role for screening but hope for the future
Phrase rank #1 · DOI 10.1136/bmj.s260
BMJ Open · 2026-02-02
Protocol for the PROSECCA study: a new approach for predicting radiotherapy outcome using artificial intelligence and electronic population-based healthcare data
Phrase rank #1 · DOI 10.1136/bmjopen-2025-104408
Journal for ImmunoTherapy of Cancer · 2026-02-02
Oncolytic virus OH2 induces PD-L1 upregulation via NF-κB signaling and synergizes with anti-PD-L1 therapy in prostate cancer through a targeted extracellular vesicle delivery system
Phrase rank #1 · DOI 10.1136/jitc-2025-013818
RMD Open · 2025-12-21
Opportunistic screening for osteoporosis and vertebral fracture using CT attenuation from 18F-fluorocholine PET/CT in patients with prostate cancer
Phrase rank #1 · DOI 10.1136/rmdopen-2025-006231
Journal for ImmunoTherapy of Cancer · 2025-11-04
433 Tumor and circulating immune dynamics in prostate cancer treated with PD-L1 blockade, radiation and hormonal therapy: a multiparametric translational analysis from the SAABR trial
Phrase rank #1 · DOI 10.1136/jitc-2025-SITC2025.0433
Journal for ImmunoTherapy of Cancer · 2025-11-04
928 VTX-P04, a self-assembling immunotherapy targeting PSCA, induces T cell responses and inhibits TRAMP-C2 tumor growth in a C57BL/6 mouse model of prostate cancer
Phrase rank #1 · DOI 10.1136/jitc-2025-SITC2025.0928
Journal for ImmunoTherapy of Cancer · 2025-11-04
654 Oncolytic viral therapy macrophage reprogramming is critical for establishing the immune infiltrate which supported by IL-15 reverses immune checkpoint inhibitor unresponsiveness of prostate cancer
Phrase rank #1 · DOI 10.1136/jitc-2025-SITC2025.0654
Journal for ImmunoTherapy of Cancer · 2025-11-04
810 Chemerin-CMKLR1 axis modulates NK cell functional responses in prostate cancer
Phrase rank #1 · DOI 10.1136/jitc-2025-SITC2025.0810
Occupational and Environmental Medicine · 2025-10-06
8292265 Multiple pesticide exposure and prostate cancer risk in a cohort of agricultural workers
Phrase rank #1 · DOI 10.1136/oemed-2025-EPICOHabstracts.192
Journal for ImmunoTherapy of Cancer · 2025-09-09
Reprogramming the immunologically cold landscape of prostate cancer through MAOA inhibition
Phrase rank #1 · DOI 10.1136/jitc-2025-012567
BMJ Open · 2026-06-28
Theory-based dyadic co-learning intervention to enhance family resilience in men with prostate cancer and their spouses in Taiwan: protocol for a randomised controlled trial
Phrase rank #2 · DOI 10.1136/bmjopen-2026-118902
Journal for ImmunoTherapy of Cancer · 2026-05-27
Gasdermin D antagonizes immunosuppression in prostate cancer by inducing LAMC2 degradation to block M2 macrophage polarization
Phrase rank #2 · DOI 10.1136/jitc-2025-014533
Journal for ImmunoTherapy of Cancer · 2026-05-13
First-in-human single-cell and TCR atlas reveals peripheral immune remodeling before and after irreversible electroporation in prostate cancer
Phrase rank #2 · DOI 10.1136/jitc-2025-014288
Journal for ImmunoTherapy of Cancer · 2026-03-25
Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancer
Phrase rank #2 · DOI 10.1136/jitc-2025-014365
Journal for ImmunoTherapy of Cancer · 2026-03-11
Dual regulation of CXCR6+CD8+ T cells modulates cytotoxic and exhaustion-associated programs during prostate cancer progression
Phrase rank #2 · DOI 10.1136/jitc-2025-014276
Journal for ImmunoTherapy of Cancer · 2026-02-24
The path forward for T cell engagers in patients with prostate cancer
Phrase rank #2 · DOI 10.1136/jitc-2025-013905
BMJ Public Health · 2026-02-17
Multilevel associations between prostate cancer testing and socioeconomic position: a population-based register study from Stockholm, Sweden
Phrase rank #2 · DOI 10.1136/bmjph-2025-003493
Journal for ImmunoTherapy of Cancer · 2026-01-30
Targeting PKMYT1 enhances antitumor immune responses to PD-L1 blockade in castration-resistant prostate cancer
Phrase rank #2 · DOI 10.1136/jitc-2025-013247
BMJ Supportive & Palliative Care · 2025-12-18
Genomic variation in symptom expression in castrate-resistant prostate cancer
Phrase rank #2 · DOI 10.1136/spcare-2025-005510
BMJ Open · 2025-11-09
A mixed-methods evaluation of a peer-led, co-produced, asset-based intervention for early diagnosis of prostate cancer for Black men: the PROCAN-B study
Phrase rank #2 · DOI 10.1136/bmjopen-2025-105803
Journal for ImmunoTherapy of Cancer · 2025-11-04
1148 Dissecting the prostate cancer microbiome and immune microenvironment to understand ethnic disparities in clinical outcomes
Phrase rank #2 · DOI 10.1136/jitc-2025-SITC2025.1148
Journal for ImmunoTherapy of Cancer · 2025-11-04
773 Spatial characterization of the immune microenvironment of localized prostate cancer reveals an immunogenic subset of high-risk tumors
Phrase rank #2 · DOI 10.1136/jitc-2025-SITC2025.0773
Occupational and Environmental Medicine · 2025-10-06
8265508 Serum organochlorine insecticide concentrations and risk of aggressive prostate cancer
Phrase rank #2 · DOI 10.1136/oemed-2025-EPICOHabstracts.201